Cost Analysis of ReSTOR® vs Monofocal IOLs in Cataract Surgery
Author Information
Author(s): Antoine Lafuma, Gilles Berdeaux
Primary Institution: Cemka, France; Alcon France
Hypothesis
This study aims to compare the lifetime costs of using the multifocal intraocular lens ReSTOR® versus monofocal IOLs in cataract surgery across four European countries.
Conclusion
ReSTOR® is a cost-saving alternative to spectacles for patients requiring cataract surgery, providing significant savings from both societal and sickness fund perspectives.
Supporting Evidence
- ReSTOR® patients purchased significantly fewer spectacles compared to those with monofocal IOLs.
- Total cost estimates for ReSTOR® were lower than for monofocal IOLs when considering societal perspectives.
- Savings from ReSTOR® ranged from €547 to €1,741 depending on the country.
Takeaway
This study shows that using a special lens called ReSTOR® during cataract surgery can save money because patients won't need to buy glasses as often.
Methodology
A Markov model was created to estimate lifetime costs for patients undergoing cataract surgery with either ReSTOR® or monofocal IOLs, following them until death.
Limitations
The study relies on model assumptions and may not account for all real-world variations in spectacle use and costs.
Participant Demographics
Patients undergoing cataract surgery in France, Germany, Italy, and Spain.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website